Cell Growth & Differentiation, Vol 8, Issue 2 121-131, Copyright © 1997 by American Association of Cancer Research

ARTICLES

Decreased immunoglobulin deposition in tumors and increased immature B cells in p53-null mice

L Shick, JH Carman, JK Choi, K Somasundaram, M Burrell, DE Hill, YX Zeng, Y Wang, KG Wiman, K Salhany, TR Kadesch, JG Monroe, LA Donehower and WS el-Deiry
Laboratory of Molecular Oncology and Cell Cycle Regulation, Howard Hughes Medical Institute, University of Pennsylvania School of Medicine, Philadelphia 19104, USA.

Recent studies have hinted that there may be a relationship between p53 and the immune response. In preliminary experiments, we found significantly decreased levels of immunoglobulin deposition in 13 of 16 p53-null tumors compared with 2 of 17 tumors derived from p53 +/- mice. We further explored the effect of p53 on B-cell development and function. p53-null mice contained more splenic white pulp and more immature B cells in the bone marrow compared with p53 +/- mice. p53-null B cells were hyperresponsive to proliferative challenge but were not more resistant to signal-induced apoptosis. Several p53 DNA-binding sites were localized to the regulatory regions of immunoglobulin heavy and light chain genes, including the KII site, which serves as an enhancer for rearrangement of the mouse kappa chain J cluster genes. Levels of p53 protein and the kappa chain sterile transcript increased after exposure of pre-B cells to the DNA damaging agents etoposide and Adriamycin. Our observations suggest that p53 may be involved in B-cell maturation and may relay certain stress signals to affect B-cell function.

This article has been cited by other articles:

				N. W. Schmidt, L. D. Mayo, D. B. Donner, and M. H. Kaplan p53 regulates Btk-dependent B cell proliferation but not differentiation J. Leukoc. Biol., April 1, 2006; 79(4): 852 - 859. [Abstract] [Full Text] [PDF]

				H. Hase, Y. Kanno, H. Kojima, C. Morimoto, K. Okumura, and T. Kobata CD27 and CD40 Inhibit p53-independent Mitochondrial Pathways in Apoptosis of B Cells Induced by B Cell Receptor Ligation J. Biol. Chem., November 27, 2002; 277(49): 46950 - 46958. [Abstract] [Full Text] [PDF]

				W. Jiang, H. N. Ananthaswamy, H. K. Muller, A. Ouhtit, S. Bolshakov, S. E. Ullrich, A. K. El-Naggar, and M. L. Kripke UV irradiation augments lymphoid malignancies in mice with one functional copy of wild-type p53 PNAS, July 24, 2001; (2001) 171066498. [Abstract] [Full Text] [PDF]

				X. Zou, F. Cong, M. Coutts, G. Cattoretti, S. P. Goff, and K. Calame p53 Deficiency Increases Transformation by v-Abl and Rescues the Ability of a C-Terminally Truncated v-Abl Mutant To Induce Pre-B Lymphoma In Vivo Mol. Cell. Biol., January 15, 2000; 20(2): 628 - 633. [Abstract] [Full Text]

				I. Unnikrishnan, A. Radfar, J. Jenab-Wolcott, and N. Rosenberg p53 Mediates Apoptotic Crisis in Primary Abelson Virus-Transformed Pre-B Cells Mol. Cell. Biol., July 1, 1999; 19(7): 4825 - 4831. [Abstract] [Full Text] [PDF]

				M. Wu, R. E. Bellas, J. Shen, and G. E. Sonenshein Roles of the Tumor Suppressor p53 and the Cyclin-dependent Kinase Inhibitor p21WAF1/CIP1 in Receptor-mediated Apoptosis of WEHI 231 B Lymphoma Cells J. Exp. Med., May 18, 1998; 187(10): 1671 - 1679. [Abstract] [Full Text] [PDF]

				W. Jiang, H. N. Ananthaswamy, H. K. Muller, A. Ouhtit, S. Bolshakov, S. E. Ullrich, A. K. El-Naggar, and M. L. Kripke UV irradiation augments lymphoid malignancies in mice with one functional copy of wild-type p53 PNAS, August 14, 2001; 98(17): 9790 - 9795. [Abstract] [Full Text] [PDF]